Xuewei Cui

5.7k citations
37 papers · 4.1k · 5 hit papers · h-index 16

Impact in

Papers in

Xuewei Cui

35 papers receiving 4.0k citations

Xuewei Cui's Hit Papers

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes 2021 · 1.2k citations
1.2k0+2+5Years since publication4008001.2k

Peers

Xuewei Cui
Comparison fields: 5 of 96
  • Endocrinology, Diabetes and Metabolism 2.6k
  • Pharmacology 841
  • Endocrine and Autonomic Systems 204
  • Physiology 675
  • Surgery 848
Replace Zvonko Miličević with:
Zvonko Miličević United States
Salvatore Calanna Denmark
Laura Fernández Landó United States
Yukiko Onishi Japan
Michael Trautmann United States
Klaus A. Dugi Germany
Carol Wysham United States
Kristin Taylor United States
Murray Stewart United Kingdom
James F. List United States
Xuewei Cui relative to Zvonko Miličević United States Zvonko Miličević's profile →
Citations per field
00.5×1.5×2.1×
Zvonko Miličević · 1×
Citations per year

Countries citing papers authored by Xuewei Cui

Since Specialization
Citations

This map shows the geographic impact of Xuewei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Cui more than expected).

Fields of papers citing papers by Xuewei Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Cui. The network helps show where Xuewei Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Xuewei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuewei Cui Line = papers co-authored together Xuewei Cui links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Hit paper breakdown →
20211229
2
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Hit paper breakdown →
2021707
3
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Hit paper breakdown →
2018638
4
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Hit paper breakdown →
2018636
5
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
Hit paper breakdown →
2020241
6 2020178
7 202094
8 201580
9 202045
10 202339
11 201736
12 202136
13 201927
14 202220
15 201717
16 202017
17 202013
18 20219
19 20228
20 20207

About Xuewei Cui

Xuewei Cui is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 37 papers that have together received 4.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Metabolism, Diabetes, and Cancer (7 papers), Neonatal Respiratory Health Research (4 papers), Congenital Diaphragmatic Hernia Studies (3 papers), Diabetes Management and Research (2 papers), Gastrointestinal motility and disorders (2 papers), Infant Nutrition and Health (2 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.6k citations), Pharmacology (841 citations), Endocrine and Autonomic Systems (204 citations), Physiology (675 citations) and Surgery (848 citations). Xuewei Cui has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Juan P. Frías, Laura Fernández Landó, Julio Rosenstock, Axel Haupt, Katelyn Brown, Bing Liu, Federico C. Pérez Manghi, Brandon K. Bergman, Melanie J. Davies and Charles Benson. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Frontiers in Pediatrics, Clinical Pharmacokinetics and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact